Gene Editing: How Can You Ask "Whether" If You Don't Know "How"?

emerging medical technologies gene editing reproductive medicine research ethics translational research

Journal

The Hastings Center report
ISSN: 1552-146X
Titre abrégé: Hastings Cent Rep
Pays: United States
ID NLM: 0410447

Informations de publication

Date de publication:
05 2021
Historique:
entrez: 24 5 2021
pubmed: 25 5 2021
medline: 26 11 2021
Statut: ppublish

Résumé

Though questions about whether gene editing should be done at all have dominated ethical discussion, a literature about how it can be done ethically has been growing. Work on responsible translational pathways for human germline gene editing has been criticized for focusing on the wrong questions. But questions about responsible translational pathways-questions about how gene editing could be done ethically-are, in an important sense, prior to questions about whether it is desirable and permissible. Asking "whether" questions about gene editing requires a model of what responsible clinical use of gene editing would look like.

Identifiants

pubmed: 34028822
doi: 10.1002/hast.1256
pmc: PMC8260147
mid: NIHMS1710518
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-17

Subventions

Organisme : NHGRI NIH HHS
ID : R03 HG010417
Pays : United States

Informations de copyright

© 2021 The Hastings Center.

Références

J Appl Philos. 2017 Aug;34(4):498-513
pubmed: 28919655
CRISPR J. 2019 Oct;2(5):285-292
pubmed: 31599679
Curr Stem Cell Rep. 2020;6(4):126-133
pubmed: 32844082
AMA J Ethics. 2019 Dec 1;21(12):E1042-1048
pubmed: 31876467
Trends Biotechnol. 2020 Apr;38(4):351-354
pubmed: 32014274
J Law Biosci. 2019 Aug 13;6(1):111-183
pubmed: 31666967
Am J Hum Genet. 2017 Aug 3;101(2):167-176
pubmed: 28777929
Cell. 2016 Feb 25;164(5):832-5
pubmed: 26919419
Nature. 2019 Mar;567(7747):165-168
pubmed: 30867611
CRISPR J. 2020 Oct;3(5):332-349
pubmed: 33095048
Mol Ther. 2015 Aug;23(8):1282
pubmed: 26227250
Nat Hum Behav. 2019 Mar;3(3):200
pubmed: 30953019
Am J Bioeth. 2020 Aug;20(8):7-18
pubmed: 32757931
Am J Bioeth. 2020 Aug;20(8):1-4
pubmed: 32804067
Cell Rep Med. 2020 Sep 22;1(6):100093
pubmed: 33205071
N Engl J Med. 2019 Jun 20;380(25):2391-2393
pubmed: 31091368
Nature. 2019 Jan;565(7738):135
pubmed: 30602779
Am J Bioeth. 2019 Jul;19(7):6-15
pubmed: 31237503
Nature. 2020 Feb;578(7794):229-236
pubmed: 32051598
Nature. 2020 Jul;583(7814):17-18
pubmed: 32606465

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH